X0206 3 2026-02-26 0 0002100782 Generate Biomedicines, Inc. GENB 0001443340 Bancel Stephane GENERATE BIOMEDICINES, INC. 101 SOUTH STREET, SUITE 900 SOMERVILLE MA 02143 true false false false Common Stock 460829 D Series A Preferred Stock Common Stock 724160 I By OCHA LLC Stock Option (Right to Buy) 6.10 2033-03-26 Common Stock 32916 D Stock Option (Right to Buy) 7.25 2034-02-08 Common Stock 32916 D Stock Option (Right to Buy) 9.15 2035-02-20 Common Stock 32916 D Shares held by OCHA LLC, of which the Reporting Person is the controlling unit holder and sole managing member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Each share of Series A Preferred Stock is convertible into Common Stock on a one-for-1.5190 basis at the option of the holder, and will convert automatically upon the closing of the Issuer's initial public offering into the number of shares shown in column 3 without payment of consideration. The Series A Preferred Stock has no expiration date. The shares underlying this option vest in sixteen equal quarterly installments following March 1, 2023, subject to the Reporting Person's continued service on each such vesting date. The shares underlying this option vest in sixteen equal quarterly installments following February 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The shares underlying this option vest in sixteen equal quarterly installments following February 1, 2025, subject to the Reporting Person's continued service on each such vesting date. Exhibit 24 - Power of Attorney /s/ Michael Wolf, Attorney-in-Fact 2026-02-26